Cellosaurus cell line BT 239 (CVCL

Cross-references
Cell line name	BT 239
Synonyms	BT239
Accession	CVCL_WW54
Resource Identification Initiative	To cite this cell line use: BT 239 (RRID:CVCL_WW54)
Comments	Characteristics: Low-passage-number culture. Derived from site: In situ; Brain; UBERON=UBERON_0000955.
Sequence variations	Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
Disease	Glioblastoma (NCIt: C3058) Glioblastoma (ORDO: Orphanet_360)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category	Cancer cell line
Publications	PubMed=25184684; DOI=10.1371/journal.pone.0106694; PMCID=PMC4153667 Holmberg Olausson K., Maire C.L., Haidar S., Ling J., Learner E., Nister M., Ligon K.L. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas. PLoS ONE 9:E106694-E106694(2014) PubMed=27723727; DOI=10.1038/nbt.3697; PMCID=PMC5142231 Stevens M.M., Maire C.L., Chou N., Murakami M.A., Knoff D.S., Kikuchi Y., Kimmerling R.J., Liu H.-Y., Haidar S., Calistri N.L., Cermak N., Olcum S., Cordero N.A., Idbaih A., Wen P.Y.-C., Weinstock D.M., Ligon K.L., Manalis S.R. Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate. Nat. Biotechnol. 34:1161-1167(2016)
Chemistry resources	PharmacoDB; BT239_129_2019
Encyclopedic resources	Wikidata; Q93432609
Entry history
Entry creation	06-Sep-2019
Last entry update	19-Dec-2024
Version number	8